X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
65
PharmaCompass offers a list of Bisoprolol Fumarate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bisoprolol Fumarate manufacturer or Bisoprolol Fumarate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bisoprolol Fumarate manufacturer or Bisoprolol Fumarate supplier.
PharmaCompass also assists you with knowing the Bisoprolol Fumarate API Price utilized in the formulation of products. Bisoprolol Fumarate API Price is not always fixed or binding as the Bisoprolol Fumarate Price is obtained through a variety of data sources. The Bisoprolol Fumarate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bisoprolol Fumarate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bisoprolol Fumarate, including repackagers and relabelers. The FDA regulates Bisoprolol Fumarate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bisoprolol Fumarate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bisoprolol Fumarate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bisoprolol Fumarate supplier is an individual or a company that provides Bisoprolol Fumarate active pharmaceutical ingredient (API) or Bisoprolol Fumarate finished formulations upon request. The Bisoprolol Fumarate suppliers may include Bisoprolol Fumarate API manufacturers, exporters, distributors and traders.
click here to find a list of Bisoprolol Fumarate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bisoprolol Fumarate DMF (Drug Master File) is a document detailing the whole manufacturing process of Bisoprolol Fumarate active pharmaceutical ingredient (API) in detail. Different forms of Bisoprolol Fumarate DMFs exist exist since differing nations have different regulations, such as Bisoprolol Fumarate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bisoprolol Fumarate DMF submitted to regulatory agencies in the US is known as a USDMF. Bisoprolol Fumarate USDMF includes data on Bisoprolol Fumarate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bisoprolol Fumarate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bisoprolol Fumarate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Bisoprolol Fumarate Drug Master File in Japan (Bisoprolol Fumarate JDMF) empowers Bisoprolol Fumarate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Bisoprolol Fumarate JDMF during the approval evaluation for pharmaceutical products. At the time of Bisoprolol Fumarate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Bisoprolol Fumarate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Bisoprolol Fumarate Drug Master File in Korea (Bisoprolol Fumarate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Bisoprolol Fumarate. The MFDS reviews the Bisoprolol Fumarate KDMF as part of the drug registration process and uses the information provided in the Bisoprolol Fumarate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Bisoprolol Fumarate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Bisoprolol Fumarate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Bisoprolol Fumarate suppliers with KDMF on PharmaCompass.
A Bisoprolol Fumarate CEP of the European Pharmacopoeia monograph is often referred to as a Bisoprolol Fumarate Certificate of Suitability (COS). The purpose of a Bisoprolol Fumarate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Bisoprolol Fumarate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Bisoprolol Fumarate to their clients by showing that a Bisoprolol Fumarate CEP has been issued for it. The manufacturer submits a Bisoprolol Fumarate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Bisoprolol Fumarate CEP holder for the record. Additionally, the data presented in the Bisoprolol Fumarate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Bisoprolol Fumarate DMF.
A Bisoprolol Fumarate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Bisoprolol Fumarate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Bisoprolol Fumarate suppliers with CEP (COS) on PharmaCompass.
A Bisoprolol Fumarate written confirmation (Bisoprolol Fumarate WC) is an official document issued by a regulatory agency to a Bisoprolol Fumarate manufacturer, verifying that the manufacturing facility of a Bisoprolol Fumarate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Bisoprolol Fumarate APIs or Bisoprolol Fumarate finished pharmaceutical products to another nation, regulatory agencies frequently require a Bisoprolol Fumarate WC (written confirmation) as part of the regulatory process.
click here to find a list of Bisoprolol Fumarate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bisoprolol Fumarate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bisoprolol Fumarate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bisoprolol Fumarate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bisoprolol Fumarate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bisoprolol Fumarate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bisoprolol Fumarate suppliers with NDC on PharmaCompass.
Bisoprolol Fumarate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bisoprolol Fumarate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bisoprolol Fumarate GMP manufacturer or Bisoprolol Fumarate GMP API supplier for your needs.
A Bisoprolol Fumarate CoA (Certificate of Analysis) is a formal document that attests to Bisoprolol Fumarate's compliance with Bisoprolol Fumarate specifications and serves as a tool for batch-level quality control.
Bisoprolol Fumarate CoA mostly includes findings from lab analyses of a specific batch. For each Bisoprolol Fumarate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bisoprolol Fumarate may be tested according to a variety of international standards, such as European Pharmacopoeia (Bisoprolol Fumarate EP), Bisoprolol Fumarate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bisoprolol Fumarate USP).
Market Place
